Status:
COMPLETED
Effects of Video Animation-Assisted Inhaler Medication Education on Medication Adherence, Attack Frequency, and Dyspnea for Asthma Patients
Lead Sponsor:
University of Gaziantep
Conditions:
Asthma Control Level
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Asthma is a chronic airway inflammation characterized by recurrent attacks, airway hyperresponsiveness, mucus hypersecretion, and airway obstruction. It ranks 16th among the most serious diseases in t...
Detailed Description
Asthma is a disease characterized by recurrent airway obstruction that can impair patients' quality of life and mental well-being. Asthma, which has a high prevalence among chronic diseases, is a sign...
Eligibility Criteria
Inclusion
- Patients who are:
- 18 years of age or older,
- Diagnosed with asthma for at least 6 months,
- Using at least one inhaler,
- No communication problems that would prevent them from participating in the study or receiving training,
- Literate,
- Have internet access at home or on their phone,
- Own and use a computer, tablet, or smartphone,
- Voluntarily agree to participate in the study
Exclusion
- Individuals who:
- Do not meet the inclusion criteria,
- Are unwilling to participate in the study,
- Do not own a computer, tablet, or smartphone,
- Have a psychiatric illness
Key Trial Info
Start Date :
February 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 15 2025
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT07134647
Start Date
February 1 2025
End Date
July 15 2025
Last Update
August 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gaziantep Üniversitesi
Gaziantep, Turkey (Türkiye), 27000